VeIP regimen
|
WikiDoc Resources for VeIP regimen |
|
Articles |
|---|
|
Most recent articles on VeIP regimen Most cited articles on VeIP regimen |
|
Media |
|
Powerpoint slides on VeIP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on VeIP regimen at Clinical Trials.gov Clinical Trials on VeIP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on VeIP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on VeIP regimen Discussion groups on VeIP regimen Patient Handouts on VeIP regimen Directions to Hospitals Treating VeIP regimen Risk calculators and risk factors for VeIP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for VeIP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:VeIP; VeIP Regimen; VeIP regimen; Velban-Ifosfamide-Platinol Regimen
Overview
VeIP regimen refers to a regimen consisting of vinblastine (velban), ifosfamide, mesna and cisplatin (platinol) used for the treatment of advanced-stage germ cell ovarian and testicular cancers[1]
Regimen
VeVinblastine (Velban)
IIfosfamide
PCisplatin (Platinol)
Indications
References
- ↑ 1.0 1.1 Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH (1988). "Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide". Ann Intern Med. 109 (7): 540–6. PMID 2844110.